# GENEOS Therapeutics, Inc. — Form D

GENEOS Therapeutics, Inc. of PLYMOUTH MEETING, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-28. The offering totals $25.0M, of which $17.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-28
- Form: D
- Accession: 0001769177-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $17.2M
- Remaining: $7.8M
- Investors: 9
- Date of first sale: 2022-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-439281

## Issuer

- Name: GENEOS Therapeutics, Inc.
- CIK: 0001769177
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 660 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462
- Phone: (267) 440-4232

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| Samuel Broder | Director | Plymouth Meeting, PA |
| Casey Cunningham | Director | Milwaukee, WI |
| Ted Fjallman | Director | Philadelphia, PA |
| Eadie James | Director | Plymouth Meeting, PA |
| Joseph Kim | Director | London, X0 |
| Sangwoo Lee | Director | Plymouth Meeting, PA |
| Niranjan Sardesai | Director | Plymouth Meeting, PA |
| Niranjan Sardesai | Executive Officer | Plymouth Meeting, PA |
| Laurent Y Humeau | Director | Plymouth Meeting, PA |
| James Y Eadie | Director | Plymouth Meeting, PA |
| Niranjan Y Sardesai | Director | Plymouth Meeting, PA |
| Niranjan Y Sardesai | Executive Officer | Plymouth Meeting, PA |
| Samuel Y Broder | Director | Plymouth Meeting, PA |
| Sangwoo Y Lee | Director | Plymouth Meeting, PA |
| Casey Y Cunningham | Director | Plymouth Meeting, PA |
| Ted Y Fjallman | Director | Plymouth Meeting, PA |
| J. Joseph Kim | Director | Plymouth Meeting, PA |
| Casey Joseph Cunningham | Director | Plymouth Meeting, PA |
| Samuel Joseph Broder | Director | Plymouth Meeting, PA |
| Sangwoo Joseph Lee | Director | Plymouth Meeting, PA |
| Samuel Y Dr. Broder | Director | Plymouth Meeting, PA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-04-13](https://search.stillhousedata.com/formd/0001769177-23-000001) | D | $10.0M | $5.0M |
| [2020-11-17](https://search.stillhousedata.com/formd/0001769177-20-000003) | D | $12.0M | $10.4M |
| [2019-02-27](https://search.stillhousedata.com/formd/0001769177-19-000001) | D | $10.5M | $4.5M |

## More

- [CIK 1769177 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1769177&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001769177-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.